Drug Type Small molecule drug |
Synonyms NW3237 |
Target |
Action inhibitors |
Mechanism ATR inhibitors(Serine-protein kinase ATR inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Brain metastases | Preclinical | United States | 13 Feb 2023 | |
| Brain metastases | Preclinical | China | 13 Feb 2023 |





